Complete pathological response in patients with locally advanced cancer of breast and positive Her2/neu with neoadjuvant chemotherapy

被引：0
|
作者：
Heidy Cedeño
Rafael Araúz
Fernando Cebamanos
Idalmis de Torraza
Ana Porcell
机构：
[1] Instituto Oncológico Nacional,Department Internal Medicine
[2] Instituto Oncológico Nacional,Department of Medical Oncology
[3] Department of Radiation Oncology Instituto Oncológico Nacional,Department of Pathology
[4] Instituto Oncológico Nacional,undefined
来源：
BMC Cancer | / 7卷 / Suppl 1期
关键词：
Trastuzumab; Axillary Lymph Node; Anthracyclines; Advanced Breast Cancer; Complete Pathological Response;
D O I：
10.1186/1471-2407-7-S1-A50
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Predictors of complete pathological response to neoadjuvant chemotherapy in patients with HER2 overexpressing breast cancer
    Boudaouara, O.
    Ben Makhlouf, W.
    Makni, S.
    Mellouli, M.
    Ben Kridis, W.
    Boudawara, T. Sellami
    Chaari, C.
    VIRCHOWS ARCHIV, 2024, 485 : S189 - S190
  • [2] Retrospective analysis of complete pathological response in locally advanced HER2 positive breast cancer patients treated with neoadjuvant chemotherapy associated to trastuzumab at Brazilian National Cancer Institute
    Nunes, A. S.
    Goncalves, A.
    Ominelli, J.
    Costa, S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [3] Pathological complete response to neoadjuvant chemotherapy and outcomes in Her-2 negative locally advanced breast cancer
    Patel, A. B.
    Sharma, M.
    Joga, S.
    Goel, S.
    Doval, D. C.
    Talwar, V.
    Goyal, S.
    Batra, U.
    ANNALS OF ONCOLOGY, 2023, 34 : S1481 - S1482
  • [4] Association of HER2/neu with complete response in breast carcinoma with neoadjuvant chemotherapy
    Peiró, G
    Adrover, E
    Aranda, FI
    Alenda, C
    Payá, A
    Seguí, J
    MODERN PATHOLOGY, 2006, 19 : 38A - 38A
  • [5] Association of HER2/neu with complete response in breast carcinoma with neoadjuvant chemotherapy
    Peiró, G
    Adrover, E
    Aranda, FI
    Alenda, C
    Payá, A
    Seguí, J
    LABORATORY INVESTIGATION, 2006, 86 : 38A - 38A
  • [6] Complete pathological response in patients with HER2 positive breast cancer treated with neoadjuvant therapy in Colombia
    Rodriguez, Mauricio
    Gonzalez, Diego M.
    El-Sharkawy, Farah
    Castano, Mileny
    Madrid, Jorge
    BIOMEDICA, 2023, 43 (03): : 396 - 405
  • [7] ESTROGEN RECEPTOR AS A NEGATIVE PREDICTOR OF COMPLETE PATHOLOGICAL RESPONSE IN HER2 POSITIVE LOCALLY ADVANCED BREAST CANCER
    Canario, Rita
    Cruz, Jorge
    Casalta-Lopes, Joao
    Goncalves, Bruno
    Mariano, Monica
    Broco, Sofia
    Pais, Ana
    Pazos, Isabel
    Carvalho, Teresa
    Pego, Antonio
    Madeira, Pedro
    Sousa, Gabriela
    Gervasio, Helena
    BREAST, 2015, 24 : S46 - S46
  • [8] Usefulness of neoadjuvant chemotherapy in patients with luminal HER2(-) locally advanced breast cancer
    Kim, H. S.
    ANNALS OF ONCOLOGY, 2017, 28
  • [9] Pathological complete response with neoadjuvant (NA) chemotherapy (trastuzumab (T) and docetaxel (D)) in HER2 positive (3+) locally advanced (LA) breast cancer (BC) patients.
    Moluçon, C
    Vanlemmens, L
    Chollet, P
    Weber, B
    Beal, D
    Mayer, F
    Benoit, L
    Zanetta, S
    Mery-Mignard, D
    Vasseur, B
    Arnould, L
    Coudert, B
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S59 - S59
  • [10] Neoadjuvant chemotherapy versus neoadjuvant hormonal therapy in postmenopausal women with ER-positive, HER2/neu negative locally advanced breast cancer
    Ambros, Tadeu Frantz
    Reis, Isildinha M.
    Bagga, Dilprit
    Villasboas, Jose Caetano
    Blieden, Clifford
    Sujoy, Victoria
    Wright, Jean L.
    Saigal, Kunal
    Fernandez, Carmen Gomez
    Hurley, Judith
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345